106 related articles for article (PubMed ID: 21943855)
21. Farming and the prevalence of non-reversible airways obstruction: results from a population-based study.
Lamprecht B; Schirnhofer L; Kaiser B; Studnicka M; Buist AS
Am J Ind Med; 2007 Jun; 50(6):421-6. PubMed ID: 17497693
[TBL] [Abstract][Full Text] [Related]
22. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.
Lindberg A; Larsson LG; Rönmark E; Jonsson AC; Larsson K; Lundbäck B
COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672
[TBL] [Abstract][Full Text] [Related]
23. Is chronic obstructive pulmonary disease associated with increased arterial stiffness?
Janner JH; McAllister DA; Godtfredsen NS; Prescott E; Vestbo J
Respir Med; 2012 Mar; 106(3):397-405. PubMed ID: 22136986
[TBL] [Abstract][Full Text] [Related]
24. Lung function changes following methacholine inhalation in COPD.
Walker PP; Hadcroft J; Costello RW; Calverley PM
Respir Med; 2009 Apr; 103(4):535-41. PubMed ID: 19081234
[TBL] [Abstract][Full Text] [Related]
25. Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada.
Tan WC; Bourbeau J; FitzGerald JM; Cowie R; Chapman K; Hernandez P; Buist SA; Sin DD
Int J Tuberc Lung Dis; 2011 Dec; 15(12):1691-8. PubMed ID: 22118181
[TBL] [Abstract][Full Text] [Related]
26. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
27. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
[TBL] [Abstract][Full Text] [Related]
28. MK-0633, a potent 5-lipoxygenase inhibitor, in chronic obstructive pulmonary disease.
Bernstein JA; Liu N; Knorr BA; Smugar SS; Hanley WD; Reiss TF; Greenberg S
Respir Med; 2011 Mar; 105(3):392-401. PubMed ID: 20970976
[TBL] [Abstract][Full Text] [Related]
29. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
Diba C; King GG; Berend N; Salome CM
Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
31. Exercise duration rather than peak oxygen uptake better correlates with Fev1 and inspiratory capacity in chronic obstructive pulmonary disease.
Metin G; Oztürk L; Duman ES; Demir T
Arch Med Res; 2007 Nov; 38(8):876-81. PubMed ID: 17923270
[TBL] [Abstract][Full Text] [Related]
32. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
33. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
Medbø A; Melbye H
Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
[TBL] [Abstract][Full Text] [Related]
34. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.
Bridevaux PO; Gerbase MW; Probst-Hensch NM; Schindler C; Gaspoz JM; Rochat T
Thorax; 2008 Sep; 63(9):768-74. PubMed ID: 18505800
[TBL] [Abstract][Full Text] [Related]
35. Preoperative use of inhaled tiotropium in lung cancer patients with untreated COPD.
Kobayashi S; Suzuki S; Niikawa H; Sugawara T; Yanai M
Respirology; 2009 Jul; 14(5):675-9. PubMed ID: 19476597
[TBL] [Abstract][Full Text] [Related]
36. Effect of preceding inspiratory speed and end-inspiratory pause on forced expiratory manoeuvre in healthy subjects and chronic obstructive pulmonary disease patients.
Boni E; Chiari S; Trigiani M; Gatta D; Pini L; Tantucci C
Respiration; 2009; 78(3):270-7. PubMed ID: 19299889
[TBL] [Abstract][Full Text] [Related]
37. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities.
Miravitlles M; Soriano JB; García-Río F; Muñoz L; Duran-Tauleria E; Sanchez G; Sobradillo V; Ancochea J
Thorax; 2009 Oct; 64(10):863-8. PubMed ID: 19553233
[TBL] [Abstract][Full Text] [Related]
39. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC.
Fukahori S; Matsuse H; Takamura N; Hirose H; Tsuchida T; Kawano T; Fukushima C; Mizuta Y; Kohno S
Int J Clin Pract; 2009 Feb; 63(2):269-74. PubMed ID: 19196365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
